Toward optimal health: the experts discuss weight control drugs. Interview by Jodi Godfrey Meisler.
G L
GL
Blackburn
M H
MH
Fernstrom
D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D001067:Appetite Depressants / Q000627:therapeutic use*; D015992:Body Mass Index; D003376:Counseling; D003503:Cyclobutanes / Q000627:therapeutic use; D004038:Diet, Reducing; D004359:Drug Therapy, Combination; D015444:Exercise; D005260:Female; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D020738:Leptin / Q000627:therapeutic use; D008019:Life Style; D009765:Obesity / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D000077403:Orlistat; D010353:Patient Education as Topic; D018579:Patient Selection; D011320:Primary Health Care / Q000379:methods; D014481:United States / Q000453:epidemiology; D015431:Weight Loss / Q000187:drug effects; D016387:Women's Health
D019440:Anti-Obesity Agents; D001067:Appetite Depressants; D003503:Cyclobutanes; D007783:Lactones; D020738:Leptin; D000077403:Orlistat; C058254:sibutramine